• A 2-center review of histopathology of variants of upper urinary tract urothelial carcinoma and their impact on clinical outcomes
• A case of urothelial carcinoma with successful continuation of enfortumab vedotin without dose reduction despite grade 3 diffuse erythema with fever
• A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma
• A histopathological and epidemiological study of urothelial carcinoma at a tertiary care centre in Peshawar, Pakistan
• A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma
• A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital
• A review of the current standing of microRNA expression in canine urothelial carcinoma
• A review of urinary bladder microbiome in patients with bladder cancer and its implications in bladder pathogenesis
• Acrodermatitis continua of Hallopeau upon PD-L1 therapy for metastatic urothelial carcinoma
• Adjuvant immune checkpoint inhibitors for urothelial carcinoma: systematic review and Meta-analysis
• Adoption of robot-assisted radical nephroureterectomy permits a minimally invasive option for management of upper tract urothelial carcinoma in geriatric patients: comparison with non-geriatric patients with intermediate-term oncologic follow-up
• An Extremely Rare Case of a 24-Year-Old Female Diagnosed With High-Grade Muscle-Invasive Urothelial Carcinoma in the Bladder
• Analysis of preoperative nutrition, immunity and inflammation correlation index on the prognosis of upper tract urothelial carcinoma surgical patients: a retrospective single center study
• Antibody-drug conjugates combined with immunotherapy: a potential game changer in the treatment of upper tract urothelial carcinoma
• Automatic analysis of nuclear features reveals a non-tumoral predictor of tumor grade in bladder cancer
• Avelumab first-line maintenance in advanced urothelial carcinoma: Complete screening for prognostic and predictive factors using machine learning in the JAVELIN Bladder 100 phase 3 trial
• Bacillus Calmette-Guérin (BCG)-Induced Pneumonitis: A Case Report
• Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter Study
• C-reactive Protein Is a Prognostic Factor for Survival in Metastatic Upper Tract Urothelial Carcinoma Patients Receiving Pembrolizumab
• C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma
• Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models
• Cigarette smoking-related OLC1 overexpression associated with poor prognosis in bladder urothelial carcinoma
• Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy
• Clinical Presentation, Tumor Characteristics, and Management of Intradiverticular Transitional Cell Carcinoma of the Urinary Bladder: A Systematic Review
• Clinical, Pathological Characteristics and Progression of Urothelial Bladder Cancer in Young Adult Patients. Our Experience and Literature Review
• CT and MRI features of sarcomatoid urothelial carcinoma of the bladder and its differential diagnosis with conventional urothelial carcinoma
• Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study
• Cutaneous Metastasis Following a Six-Year History of Bladder Urothelial Carcinoma in Situ: A Case Report
• Detection of Muscularis propria Invasion in Urothelial Carcinoma Using Artificial Intelligence
• Development and validation of competing risk nomograms for predicting cancer‑specific mortality in non-metastatic patients with non‑muscle invasive urothelial bladder cancer
• Diagnostic performance of photodynamic diagnosis with oral 5-aminolevulinic acid for upper tract- and bladder urothelial carcinoma: a single-centre, retrospective analysis
• Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis
• Do we need a re-TUR after en bloc resection of T1 stage bladder cancer?
• Editorial Comment on "Real-world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey"
• Efficacy and safety of antibody-drug conjugates in the treatment of urothelial cell carcinoma: a systematic review and meta-analysis of prospective clinical trials
• Enfortumab vedotin and pembrolizumab combination as a relevant game changer in urothelial carcinoma: What is left behind?
• Enfortumab Vedotin for Elderly Advanced Urothelial Carcinoma Patients or Those With a Poor Performance Status
• Enhancing bladder cancer diagnosis through transitional cell carcinoma polyp detection and segmentation: an artificial intelligence powered deep learning solution
• Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study
• Erstlinien-Erhaltungstherapie bei erwachsenen Patienten mit lokal fortgeschrittenem oder metastasiertem Urothelkarzinom, die nach einer platinbasierten Chemotherapie progressionsfrei sind
• Frontline immune checkpoint inhibitors in patients ≥ 90 years with advanced urothelial cancer: a single center experience
• Gambogic Acid Improves Cisplatin Resistance of Bladder Cancer Cells through the Epithelial-Mesenchymal Transition Pathway Mediated by the miR-205-5p/ZEB1 Axis
• Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesions
• Grading urothelial carcinoma with probe-based confocal laser endomicroscopy during flexible cystoscopy
• Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study
• Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer
• HISTOPATHOLOGIC FEATURES OF KIDNEY TUMORS AND COMPARISON OF PATIENTS TREATED WITH RADICAL AND PARTIAL NEPHRECTOMY AT OSIJEK UNIVERSITY HOSPITAL CENTER FROM 2017 UNTIL THE END OF 2021
• Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours
• Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
• Impact of Cutaneous Squamous Cell Carcinoma Histologic Features on Percent Interrater Agreement Regarding Tumor Differentiation
• Impact of Intestinal Urinary Diversion on the Risk of Fracture and Loss of Bone Mass: A Systematic Review
• Incidental Pathogenic Variants in Renal Cell and Urothelial Carcinoma: Is It Time for Universal Screening?
• Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing
• Is HER2 the New NECTIN4 in Advanced Urothelial Cancer?
• It's not always histiocytic sarcoma: Immunocytochemistry to identify two unusual tumors in a Bernese Mountain dog
• Kohortenstudie beim metastasierten und nicht resezierbaren, lokal fortgeschrittenen Urothelkarzinom
• Letter re: High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma
• Letter to the editor for the article "Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies"
• Marked Response to Nivolumab by a Patient With SMARCA4-Deficient Undifferentiated Urothelial Carcinoma Showing High PD-L1 Expression: A Case Report
• Metastatic Bladder Urothelial Carcinoma Masquerading as Myositis
• Molecular Pathology of Urothelial Carcinoma
• Muscle-invasive and metastatic urothelial carcinoma of the urinary bladder : Current state of histopathologic, molecular, and immunologic prognostic and predictive factors
• No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomy
• Nuclear long diameter as a new criterion to distinguish high-grade urothelial carcinoma cells from benign reactive cells
• Occult clear cell carcinoma arising from oxidative stress-exposed cystic adenomyosis: A case report
• On the Road Towards Curing Advanced Bladder Cancer
• Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
• Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases
• Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study
• Perioperative management of upper tract urothelial carcinoma in the Nordic countries
• Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls
• Possible adverse events of imidazole antifungal drugs during treatment of vulvovaginal candidiasis: analysis of the FDA Adverse Event Reporting System
• Preoperative analysis of factors associated with prolonged pneumoretroperitoneum time during retroperitoneal laparoscopic nephroureterectomy for upper tract urothelial carcinoma
• Primary exophytic urothelial carcinoma of the bladder: A case report
• Prospective evaluation of surgical margins in non-muscle invasive bladder cancer following primary transurethral resection
• Recent Advances of Neoadjuvant Immunotherapy for Urothelial Bladder Cancer
• Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution
• Relapse and Survival in Bladder Cancer Patients Undergoing microRNA-129 and microRNA-145 Assays
• Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
• Rostral cranial fossa and sinonasal neoplasms with cribriform plate involvement in 32 dogs and 17 cats
• Several key and difficult issues related to the grading of urothelial carcinoma of urinary bladder
• Similar genetic profile in early and late stage urothelial tract cancer
• Single-center analysis of a real-world cohort of patients with metastatic urothelial carcinoma evaluated by NGS: molecular landscape and efficacy of targeted therapies
• Small Bowel Obstruction Secondary to Metastatic Urothelial Cell Carcinoma With Plasmacytoid Features: A Case Report
• Systematic Review of the Role of BCG in the Treatment of Urothelial Carcinoma of the Prostatic Urethra
• Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy
• The impact of double-J ureteral stenting before radical cystectomy on the development of upper tract urothelial carcinoma
• The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
• The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells In Vitro
• The role of immunotherapy in urological cancers
• Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy
• Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers
• Tumor necrosis in magnetic resonance imaging predicts urothelial carcinoma with squamous differentiation in muscle-invasive bladder carcinoma
• Urinary Tract Cytopathology: Current and Future Impact on Patient Care
• UROTHELIAL CARCINOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN CROATIA - A SINGLE-CENTER STUDY
• Urothelial carcinoma in a mule
• Using machine learning to develop preoperative model for lymph node metastasis in patients with bladder urothelial carcinoma
• Violation of onco-surgical principles is associated with survival outcomes in upper tract urothelial carcinomas after radical nephroureterectomy
• What About Variant Histologies in Bladder Cancer?
• What Is the Future of Cystoscopy for Detecting Urothelial Carcinoma?